PCRX Insider Trading
Insider Ownership Percentage: 6.40%
Insider Buying (Last 12 Months): $136,240.40
Insider Selling (Last 12 Months): $653,601.25
Pacira BioSciences Insider Trading History Chart
This chart shows the insider buying and selling history at Pacira BioSciences by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Pacira BioSciences Share Price & Price History
Current Price: $24.91
Price Change: ▼ Price Decrease of -0.39 (-1.54%)
As of 03/28/2025 05:00 PM ET
Pacira BioSciences Insider Trading History
Pacira BioSciences Institutional Trading History
Data available starting January 2016
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Read More on Pacira BioSciences
Today's Range
Now: $24.91
52 Week Range
Now: $24.91
Volume
586,571 shs
Average Volume
937,280 shs
Market Capitalization
$1.15 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.86
Who are the company insiders with the largest holdings of Pacira BioSciences?
Pacira BioSciences' top insider shareholders include:
- David M Stack (CEO)
- Gary W Pace (Director)
- Daryl Gaugler (COO)
- Frank D Lee (CEO)
- Kristen Williams (Insider)
- Jonathan Slonin (Insider)
- Roy Winston (Insider)
- Lauren Riker (SVP)
- Charles A Reinhart III (CFO)
- Kristen Marie Williams (Insider)
- Lauren Bullaro Riker (SVP)
- Mark A Kronenfeld (Director)
- Mark Froimson (Director)
- Paul J Hastings (Director)
- Marcelo Bigal (Director)
Learn More about top insider investors at Pacira BioSciences.
Who are the major institutional investors of Pacira BioSciences?
Which institutional investors are selling Pacira BioSciences stock?
In the last quarter, PCRX stock was sold by these institutional investors:
- Pacer Advisors Inc.
- Invesco Ltd.
- Arrowstreet Capital Limited Partnership
- Marshall Wace LLP
- Cubist Systematic Strategies LLC
- Trexquant Investment LP
- AQR Capital Management LLC
- Schonfeld Strategic Advisors LLC
During the previous year, company insiders that have sold Pacira BioSciences company stock include:
- David M Stack (CEO)
- Gary W Pace (Director)
- Daryl Gaugler (COO)
- Frank D Lee (CEO)
- Kristen Williams (Insider)
Learn More investors selling Pacira BioSciences stock.
Which institutional investors are buying Pacira BioSciences stock?
During the previous quarter, PCRX stock was purchased by institutional investors including:
- Point72 Asset Management L.P.
- Jacobs Levy Equity Management Inc.
- Balyasny Asset Management L.P.
- Nuveen Asset Management LLC
- Ameriprise Financial Inc.
- ExodusPoint Capital Management LP
- Northern Trust Corp
- Norges Bank
In the previous year, these company insiders have bought Pacira BioSciences stock:
- David M Stack (CEO)
- Gary W Pace (Director)
- Daryl Gaugler (COO)
Learn More investors buying Pacira BioSciences stock.